Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jan 17, 2018, 19:00 ET GC Pharma Confirms Phase 2/3 Clinical Trial of New Protein Therapy for Hepatitis B

GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, today announced that it will proceed...


Jan 17, 2018, 16:09 ET Overall Survival Analysis From KYPROLIS® (Carfilzomib) Phase 3 ASPIRE Trial Published in the Journal of Clinical Oncology

Amgen (NASDAQ:AMGN) today announced that the Journal of Clinical Oncology published positive overall survival (OS) findings from the final analysis...


Jan 17, 2018, 15:37 ET Researchers Discover Structure of Anti-Aging Hormone

A new study reveals the molecular structure of a protein called alpha(α)Klotho, and how it helps to transmit a hormonal signal that slows...


Jan 17, 2018, 14:28 ET OBI Pharma erhält FDA-Genehmigung des IND-Antrags auf Phase-1-Studie eines monoklonalen Antikörpers zur Krebsimmuntherapie (OBI-888).

In erster klinischer Studie werden Sicherheit und vorläufige Aktivität einer passiven Immuntherapie auf Basis eines monoklonalen Antikörpers...


Jan 17, 2018, 10:57 ET Celsee and IncellDx Sign Co-Commercialization Agreement Following Successful Lung Cancer/CTC PD-L1 Feasibility Study

Celsee, Inc., an innovator of platforms for comprehensive single-cell identification, analysis and retrieval, announced today that they have...


Jan 17, 2018, 09:15 ET MiMedx Announces the Enrollment of the First Patients in the Phase 3 Clinical Trial of AmnioFix® Injectable for Achilles Tendonitis

MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing...


Jan 17, 2018, 09:10 ET First Duchenne Muscular Dystrophy Patient Dosed in Systemic Microdystrophin Gene Therapy

Parent Project Muscular Dystrophy (PPMD), a nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), announced that...


Jan 17, 2018, 09:01 ET MobileODT Technology Improves Cervical Cancer Detection Rates - Study

As per a new World Bank/IFC-funded study by MobileODT and Apollo Hospitals, deploying the EVA (Enhanced Visual Assessment) System at primary...


Jan 17, 2018, 09:00 ET Neurim Pharmaceuticals' New Paediatric Prolonged-Release Melatonin ("PedPRM") to Be Marketed by BIOCODEX Oy in Finland

Neurim Pharmaceuticals ('Neurim') and BIOCODEX Oy ('Biocodex') announced today a license agreement in which Biocodex will obtain the exclusive...


Jan 17, 2018, 08:28 ET Technology Advancements to Conquer the Precision Medicine Market

Chimeric Antigen Receptor (CAR) T Cell therapy prove effective in treating hematological cancers, with close to 90% clinical response rate...


Jan 17, 2018, 08:10 ET OBI Pharma annonce que la FDA a approuvé une demande d'IND pour une étude de phase 1 d'immunothérapie du cancer par anticorps monoclonaux (OBI-888)

Premiers essais cliniques pour tester l'innocuité et l'activité préliminaire de l'immunothérapie passive reposant sur des anticorps monoclonaux...


Jan 17, 2018, 08:00 ET Regen BioPharma, Inc.'s Medicinal Chemistry Program has Identified Additional Compounds That Activate NR2F6

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) continues to develop small molecule drugs that activate NR2F6 and has identified a key...


Jan 17, 2018, 08:00 ET Bayer to Highlight New Research at ASCO GI 2018 Cancer Symposium

Bayer announced today that new data from the continued research on Stivarga® (regorafenib) and Nexavar® (sorafenib) in advanced liver, colorectal...


Jan 17, 2018, 07:00 ET BioLineRx Announces Partial Monotherapy Results from Phase 2a COMBAT Study in Pancreatic Cancer

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today partial...


Jan 17, 2018, 07:00 ET Curis Announces Initiation of Phase 1 Trial of CA-4948, a Small Molecule Inhibitor of IRAK4 Kinase in Patients with Lymphoma

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development and commercialization of innovative and effective...


Jan 17, 2018, 05:00 ET OBI Pharma Announces FDA Clearance Of IND Application For A Phase 1 Study Of A Monoclonal Antibody Cancer Immunotherapy (OBI-888).

OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), today announced that the U.S. Food and Drug Administration (FDA) has cleared an...


Jan 17, 2018, 01:18 ET Novartis granted US FDA Priority Review for Kymriah™ (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL

Novartis today announced that its supplemental Biologics License Application (sBLA) for Kymriah™ (tisagenlecleucel) suspension for intravenous...


Jan 17, 2018, 01:00 ET Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST® for Prophylaxis of Hereditary Angioedema Attacks

Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announced today that the U.S. Food and Drug Administration (FDA) has...


Jan 16, 2018, 13:00 ET goBalto Joins The Avoca Quality Consortium

goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today its membership in The Avoca Quality Consortium...


Jan 16, 2018, 11:00 ET Thirty-Year National Study Shows Women Who Breastfeed Six Months or More Reduce Their Diabetes Risk by 50 Percent

Breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years,...


Jan 16, 2018, 10:56 ET New Year Rings In New Hope for People with Lupus

Singer Selena Gomez brought lupus awareness to new heights in early 2017 when she shared her compelling story about having a kidney transplant...


Jan 16, 2018, 09:00 ET MyDx's Biopharmaceutical Division Commences Clinical Trials On Its Unique MyDx360 Pain Management Formula

MyDx, Inc. (OTCQB: MYDX), a science and technology company and creator of MyDx® (My Diagnostic), the first multi-use handheld chemical analyzer...


Jan 16, 2018, 08:54 ET Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps FDA is taking to enhance transparency of clinical trial information to support innovation and scientific inquiry related to new drugs

Scientific progress and new drug innovation don't take place in a vacuum. The exchange of information that informs decisions to undertake research,...


Most Viewed